Modifying oral cytotoxics: what are the considerations?

No Thumbnail Available
File version
Author(s)
Haywood, Alison
Glass, BD
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)

Andrew Daniels

Date
2009
Size
File type(s)
Location
License
Abstract

It is well known that Australia's population is ageing and that the incidence of cancer is highest in older age groups, so despite the fact that cancer incidence rates in Australia for both men and women are projected to remain stable to 2011.1 the total number of new cases of cancer is projected to increase. To reduce the resulting burden on the health care system it is imperative that patients be treated at home. The introduction of several new oral cytotoxics, allowing the administration of chemotherapeutic agents outside of traditional clinic settings, is making this goal attainable.2 While studies have shown that patients receiving chemotherapy prefer the oral route of administration over the parenteral route, there are many new challenges in administering these agents in non-traditional environments.2,3 Pharmacists, because of their accessibility, have an important role to play in counselling patients on the safe and effective use of these cytotoxics, thus playing a pivotal role in the achievement of favourable therapeutic outcomes for these patients.

Journal Title

The Australian Pharmacist

Conference Title
Book Title
Edition
Volume

28

Issue

8

Thesis Type
Degree Program
School
DOI
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement

Self-archiving of the author-manuscript version is not yet supported by this publisher. Please use the hypertext link above to access the journal's website or contact the author for more information.

Item Access Status
Note
Access the data
Related item(s)
Subject

Pharmaceutical Sciences

Pharmacology and Pharmaceutical Sciences

Persistent link to this record
Citation
Collections